http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9958566-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5272f5bf51d59db644f55363255e25f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10afea640e3b96a7394c3c166cfa819b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ffda904bff9a49c8bebd2a3e0a7ba4c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-32
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-32
filingDate 1999-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a738088d701d11f6ab65a5e69210ebd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e1d8935870f259196a95c8070f91a51
publicationDate 1999-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9958566-A1
titleOfInvention INHIBITION OF p53 FUNCTION BY A p53-DERIVED SUBSTANCE
abstract The present invention provides a substance which has the property of inhibiting the sequence specific DNA binding activity of p53, said substance being based on the fragment of the DNA binding core domain of p53. The substance is shown to inhibit p53 DNA binding in vitro and transactivation function in living cells. The invention includes the use of these substances, and in screening for mimetics.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03014144-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03014144-A2
priorityDate 1998-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9324525-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9807851-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9519367-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9806753-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5959
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406329

Total number of triples: 28.